O mercado privado de vacinas no Brasil: a mercantilização no espaço da prevenção
Autor(a) principal: | |
---|---|
Data de Publicação: | 2003 |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Cadernos de Saúde Pública |
Texto Completo: | https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2029 |
Resumo: | The main objective of this article is to analyze the vaccines market in Brazil, which is characterized as consisting of two segments with distinct practices and logics: the public segment, focused on supply within the Unified National Health System (SUS) and the private segment, organized around private clinics, physicians' offices, and similar private health facilities. The private vaccines market segment, studied here for the first time, is characterized in relation to the supply and demand structure. Historical aspects of its structure are analyzed, based on the creation of one of the first immunization clinics in the country. The attempt was to analyze this segment in relation to its economic dimensions (imports and sales), principal manufacturers, and products marketed. It economic size proved much greater than initially hypothesized. The figures allow one to view it as one of the main segments in the pharmaceutical industry in Brazil as measured by sales volume. One detects the penetration of a privatizing logic in a sphere that has always been essentially public, thereby introducing into the SUS a new space for disregarding the principles of equity and universality. |
id |
FIOCRUZ-5_596b0244981e8782fd7c6a3689ba954e |
---|---|
oai_identifier_str |
oai:ojs.teste-cadernos.ensp.fiocruz.br:article/2029 |
network_acronym_str |
FIOCRUZ-5 |
network_name_str |
Cadernos de Saúde Pública |
repository_id_str |
|
spelling |
O mercado privado de vacinas no Brasil: a mercantilização no espaço da prevençãoMercado de VacinasIndústria FarmacêuticaVacinasThe main objective of this article is to analyze the vaccines market in Brazil, which is characterized as consisting of two segments with distinct practices and logics: the public segment, focused on supply within the Unified National Health System (SUS) and the private segment, organized around private clinics, physicians' offices, and similar private health facilities. The private vaccines market segment, studied here for the first time, is characterized in relation to the supply and demand structure. Historical aspects of its structure are analyzed, based on the creation of one of the first immunization clinics in the country. The attempt was to analyze this segment in relation to its economic dimensions (imports and sales), principal manufacturers, and products marketed. It economic size proved much greater than initially hypothesized. The figures allow one to view it as one of the main segments in the pharmaceutical industry in Brazil as measured by sales volume. One detects the penetration of a privatizing logic in a sphere that has always been essentially public, thereby introducing into the SUS a new space for disregarding the principles of equity and universality.Este artigo tem como objetivo principal a análise do mercado de vacinas no Brasil, que está caracterizado como composto de dois segmentos com práticas e lógicas distintas: o segmento público voltado para a oferta ao interior do Sistema Único de Saúde (SUS) e o privado que se organiza em torno de clínicas, consultórios e outros espaços privados. O segmento privado, aqui estudado pela primeira vez, é caracterizado em relação à estrutura da oferta e da demanda. Os aspectos históricos de sua estruturação são analisados tomando-se como referência a criação de uma das primeiras clínicas de imunização do país. Busca-se caracterizar este segmento em relação à sua dimensão em termos econômicos (importações e vendas), principais fabricantes e produtos comercializados. Sua dimensão econômica que revelou-se muito superior ao inicialmente aventado. Os números obtidos permitem considerá-lo como um dos principais segmentos de mercado da indústria farmacêutica no país, em termos de volume de vendas. Detecta-se a penetração de lógicas privatizantes em um espaço que sempre foi marcadamente público, com isso introduzindo no SUS um novo espaço de quebra dos princípios da eqüidade e universalidade.Reports in Public HealthCadernos de Saúde Pública2003-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlapplication/pdfhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2029Reports in Public Health; Vol. 19 No. 5 (2003): September/OctoberCadernos de Saúde Pública; v. 19 n. 5 (2003): Setembro/Outubro1678-44640102-311Xreponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2029/4045https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2029/4046Temporão, José Gomesinfo:eu-repo/semantics/openAccess2024-03-06T15:26:47Zoai:ojs.teste-cadernos.ensp.fiocruz.br:article/2029Revistahttps://cadernos.ensp.fiocruz.br/ojs/index.php/csphttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/oaicadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2024-03-06T13:02:25.291695Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)true |
dc.title.none.fl_str_mv |
O mercado privado de vacinas no Brasil: a mercantilização no espaço da prevenção |
title |
O mercado privado de vacinas no Brasil: a mercantilização no espaço da prevenção |
spellingShingle |
O mercado privado de vacinas no Brasil: a mercantilização no espaço da prevenção Temporão, José Gomes Mercado de Vacinas Indústria Farmacêutica Vacinas |
title_short |
O mercado privado de vacinas no Brasil: a mercantilização no espaço da prevenção |
title_full |
O mercado privado de vacinas no Brasil: a mercantilização no espaço da prevenção |
title_fullStr |
O mercado privado de vacinas no Brasil: a mercantilização no espaço da prevenção |
title_full_unstemmed |
O mercado privado de vacinas no Brasil: a mercantilização no espaço da prevenção |
title_sort |
O mercado privado de vacinas no Brasil: a mercantilização no espaço da prevenção |
author |
Temporão, José Gomes |
author_facet |
Temporão, José Gomes |
author_role |
author |
dc.contributor.author.fl_str_mv |
Temporão, José Gomes |
dc.subject.por.fl_str_mv |
Mercado de Vacinas Indústria Farmacêutica Vacinas |
topic |
Mercado de Vacinas Indústria Farmacêutica Vacinas |
description |
The main objective of this article is to analyze the vaccines market in Brazil, which is characterized as consisting of two segments with distinct practices and logics: the public segment, focused on supply within the Unified National Health System (SUS) and the private segment, organized around private clinics, physicians' offices, and similar private health facilities. The private vaccines market segment, studied here for the first time, is characterized in relation to the supply and demand structure. Historical aspects of its structure are analyzed, based on the creation of one of the first immunization clinics in the country. The attempt was to analyze this segment in relation to its economic dimensions (imports and sales), principal manufacturers, and products marketed. It economic size proved much greater than initially hypothesized. The figures allow one to view it as one of the main segments in the pharmaceutical industry in Brazil as measured by sales volume. One detects the penetration of a privatizing logic in a sphere that has always been essentially public, thereby introducing into the SUS a new space for disregarding the principles of equity and universality. |
publishDate |
2003 |
dc.date.none.fl_str_mv |
2003-10-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2029 |
url |
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2029 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2029/4045 https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/2029/4046 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html application/pdf |
dc.publisher.none.fl_str_mv |
Reports in Public Health Cadernos de Saúde Pública |
publisher.none.fl_str_mv |
Reports in Public Health Cadernos de Saúde Pública |
dc.source.none.fl_str_mv |
Reports in Public Health; Vol. 19 No. 5 (2003): September/October Cadernos de Saúde Pública; v. 19 n. 5 (2003): Setembro/Outubro 1678-4464 0102-311X reponame:Cadernos de Saúde Pública instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Cadernos de Saúde Pública |
collection |
Cadernos de Saúde Pública |
repository.name.fl_str_mv |
Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br |
_version_ |
1798943352423448576 |